Process Operations Resource Center
How pharma companies are tapping into the capabilities of Product Lifecycle Management tools to address the product and process data challenge
Contrary to popular belief, biomagnetic separation is ready for large-scale processing
If not handled properly, remediation efforts can become sizable and expensive; fortunately, companies can draw on the structured remediation experiences of other companies who have emerged from crisis
How Catalent’s approach to containment mitigates cross-contamination risk and regulatory issues, ultimately safeguarding patients
White Papers: In Depth Research
Posted: Apr 28, 2015
It would be foolish to underestimate the risk associated with aseptic drug processing. Drug safety, secure uninterrupted supply, as well as regulatory imperatives dictate that drug makers create intensive and verifiable systems to assure sterility in asept
Posted: Mar 24, 2015
An important part of validating the safety function in a level instrument is the requirement for regular proof testing. However, full testing can lead to increased risk and process downtime.
Posted: Sep 05, 2014
The chemical, pharmaceutical and food industries awaken to the explosive potential of dust accumulations in the plant.
Posted: Jul 07, 2014